SDNY Patent Litigation Update: Vol. 1, No. 4


The SDNY Patent Litigation Update provides a single-resource, monthly summary of patent litigation action in SDNY including complaints filed, important decisions, and trending issues. For example, last month Judge Scheindlin dismissed Medinol’s stent patent-infringement case against Cordis and J&J for laches. Read More >


More >

Date Filed

Case Number 



Patent Number(s)

Accused Product(s)



Pfizer Inc., Pfizer Limited, and Pfizer Ireland Pharmaceuticals

Torrent Pharmaceuticals Limited and Torrent Pharma Inc.


Generic version of Viagra(R)



Hunter Douglas, Inc.

Kohl's Corporation; Welcome Industrial Corp.


Top-Down/Bottom-Up Shades (window covering product)

Significant Decisions/Court Orders

More > 

Medinol Ltd v. Cordis Corporation et al
Case Number: 1:13-cv-01408-SAS
Date: March 14, 2014
Document (Dkt. 64)

Laches ends bifurcated stent patent infringement case

More >

Lexos Media, Inc. v. Zynga Inc.
Case Number: 1:12-cv-07994-PGG
Date: March 25, 2014
Document (Dkt. 97)

Speaking objections are not allowed, and neither are whispered instructions

More >

High Point Design LLC v. Buyers Direct Inc.
Case Number: 1:11-cv-04530
Date: March 26, 2014
Document (Dkt. 121)

The other shoe drops

More >


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins Kaplan LLP | Attorney Advertising

Written by:


Robins Kaplan LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.